Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Glenmark Receives Orphan Drug Designation for Multiple Myeloma Candidate

americanpharmaceuticalreviewSeptember 18, 2019

Tag: Glenmark , Orphan , Multiple , myeloma

PharmaSources Customer Service